Skip to main content
. 2012 Jul 1;4(4):488–496. doi: 10.4161/mabs.20761

graphic file with name mabs-4-488-g6.jpg

Figure 6. B cells depletion induced by biosimilar 1B8 mAb. (A) Schedule of biosimilar 1B8 mAb administration and blood extraction. (B) B lymphocytes percentages were determined as above (see Fig. 2). (C) T cells were stained with FITC-conjugated goat anti-human CD4 and CD8 mix antibodies. NT: non-treated animals.